Anti-PRKAA2 Antibody

PRKAA2 antibody

Boster Bio Anti-PRKAA2 Antibody (Catalog # M01420). Tested in IF, WB application(s). This antibody reacts with Human.

Product Info Summary

SKU: M01420
Size: 80 µl
Reactive Species: Human
Host: Mouse
Application: IF, WB

Customers Who Bought This Also Bought

Product Name

Anti-PRKAA2 Antibody

View all PRKAA2 Antibodies

SKU/Catalog Number

M01420

Size

80 µl

Description

Boster Bio Anti-PRKAA2 Antibody (Catalog # M01420). Tested in IF, WB application(s). This antibody reacts with Human.

Storage & Handling

Maintain refrigerated at 2-8°C for up to 2 weeks. For long-term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.

Cite This Product

Anti-PRKAA2 Antibody (Boster Biological Technology, Pleasanton CA, USA, Catalog # M01420)

Host

Mouse

Contents

Purified monoclonal antibody supplied in PBS with 0.09% (W/V) sodium azide.

Clonality

Monoclonal

Clone Number

206CT5.4.2

Isotype

IgG2a,K

Immunogen

This PRKAA2 monoclonal antibody is generated from mouse immunized with PRKAA2 recombinant protein.

Reactive Species

M01420 is reactive to PRKAA2 in Human

Calculated molecular weight

62.3 kDa

Background of PRKAA2

The protein encoded by this gene is a catalytic subunit of the AMP-activated protein kinase (AMPK). AMPK is a heterotrimer consisting of an alpha catalytic subunit, and non-catalytic beta and gamma subunits. AMPK is an important energy-sensing enzyme that monitors cellular energy status. In response to cellular metabolic stresses, AMPK is activated, and thus phosphorylates and inactivates acetyl-CoA carboxylase (ACC) and beta-hydroxy beta-methylglutaryl-CoA reductase (HMGCR), key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. Studies of the mouse counterpart suggest that this catalytic subunit may control whole-body insulin sensitivity and is necessary for maintaining myocardial energy homeostasis during ischemia.

Antibody Validation

Boster validates all antibodies on WB, IHC, ICC, Immunofluorescence, and ELISA with known positive control and negative samples to ensure specificity and high affinity, including thorough antibody incubations.

View more details

Applications

M01420 is guaranteed for IF, WB Boster Guarantee

Assay Dilutions Recommendation

The recommendations below provide a starting point for assay optimization. The actual working concentration varies and should be decided by the user.

IF: 1:10-1:50
WB: 1:1000

Validation Images & Assay Conditions

Loading publications

No publications found

Do you have publications using this product? Share with us and receive a reward. Contact us for more information.

Publications not available. Please try again later.

Product has been cited in publications

No results found matching your query

  • Published: --- Journal: --- Application: --- Impact Factor: --- Species: --- PMID: --- View Article

Have you used Anti-PRKAA2 Antibody?

Share your experimental results or join a short interview to earn up to $1,000 in product credits or other rewards.

0 Reviews For Anti-PRKAA2 Antibody

Have a question?

Find answers in Q&As, reviews.

Can't find your answer?

Submit your question

0 Customer Q&As for Anti-PRKAA2 Antibody

Order DetailsPrice
M01420-80ul

80 μl

$299
M01420-400ul

400 μl

$486

Free Secondary Antibody

FREE  $95.00
FREE  $95.00
$40.00  $80.00
$75.00  $150.00
$30.00  $60.00
$75.00  $150.00
$65.00  $130.00
$67.50  $135.00
Choose an option to show lead time.
Get A Quote
In stock
Order Product
M01420
Buy one primary antibody get one 0.5ml HRP or Biotin secondary antibody for free.
*Sample sizes are prepared on demand and will take extra lead time. (cannot be conjugated)
$299.00

Troubleshooting

troubleshooting-box-image

Download troubleshooting handbooks for IHC, Western blot and ELISA for FREE.

Download Free PDFs Now

Boster Guarantee

Guaranteed product quality

Guaranteed product quality

We promise all of our products perform as described in datasheets.

This product is for Research Use Only. Not for use in diagnostic procedures.

Update date: Apr 25, 2026